Evaluation of procalcitonin as a marker of infection in a nonselected sample of febrile hospitalized patients

被引:14
作者
Muñoz, P [1 ]
Simarro, N [1 ]
Rivera, M [1 ]
Alonso, R [1 ]
Alcalá, L [1 ]
Bouza, E [1 ]
机构
[1] Univ Madrid, Hosp Gen Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid 3, Spain
关键词
D O I
10.1016/j.diagmicrobio.2004.04.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The level of procalcitonin is undetectable in healthy individuals and slightly increased in viral infections and noninfectious inflammatory responses. It has been described to be notably increased in bacterial, parasitic, or fungal infections. Procalcitonin has been reported to be a reliable marker for severe bacterial infections, although it has mainly been studied in specific entities or in selected groups of patients. We prospectively determined the procalcitonin level in 103 unselected febrile hospitalized patients. Most of them had a proven (39) or probable bacterial infection (44). Procalcitonin was more frequently positive in bacteremic patients (p = 0.01), in patients with a proven bacterial infection (p < 0.01), and in those with a high sepsis score (p < 0.005), however; when cases with proven bacterial infection were considered as a reference. the sensitivity of the test was only 54% and the specificity 70%. Procalcitonin determination should not be included systematically in the screening of febrile hospitalized patients. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 30 条
[1]   Procalcitonin in patients with and without immunosuppression and sepsis [J].
AlNawas, B ;
Shah, PM .
INFECTION, 1996, 24 (06) :434-436
[2]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[3]   The drug nexus in Africa [J].
Bernholz, CD .
JOURNAL OF GOVERNMENT INFORMATION, 2000, 27 (06) :914-916
[4]   Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation [J].
Blijlevens, NMA ;
Donnelly, JP ;
Meis, JFGM ;
De Keizer, MH ;
De Pauw, BE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (06) :889-892
[5]   Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX) [J].
Boeken, U ;
Feindt, P ;
Micek, M ;
Petzold, T ;
Schulte, HD ;
Gams, E .
CARDIOVASCULAR SURGERY, 2000, 8 (07) :550-554
[6]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[7]   Procalcitonin as a marker of sepsis [J].
Carrol, ED ;
Thomson, APJ ;
Hart, CA .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (01) :1-9
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]   Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever [J].
Chirouze, C ;
Schuhmacher, H ;
Rabaud, C ;
Gil, H ;
Khayat, N ;
Estavoyer, JM ;
May, T ;
Hoen, B .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (02) :156-161
[10]   High serum procalcitonin levels do not predict bacteremia in adult patients with acute fever [J].
Debard, AL ;
Vautrin, C ;
Pariset, C ;
Bienvenu, J ;
Monneret, G .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (06) :825-826